Contact this trialFirst, we need to learn more about you.
Plasmid
NNC0361-0041 for Type 1 Diabetes
Recruiting0 awardsPhase 1
Indianapolis, Indiana
This trial is testing a new drug to see if it is safe and tolerated by people with Type 1 Diabetes. The trial is designed so that patients don't know if they are receiving the drug or a placebo, and the doses are given incrementally to test safety.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.